Search results for " Proliferative Diabetic Retinopathy"

showing 3 items of 3 documents

Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects. The Casteldaccia Eye Study

2003

PURPOSE: To investigate the prevalence and risk factors of diabetic retinopathy in subjects aged 40 years or older living in Casteldaccia, Sicily. METHODS: A population-based survey was performed on 1,588 subjects randomly enrolled among people aged 40 years or older. A total of 1,068 persons could be examined and in 1,019 the fundus of the eye was adequately observed (64.2% of the enrolled population). Diabetic retinopathy was diagnosed by ophthalmoscopy and fundus photographs; fluorescein angiography was performed in 91% of retinopathic subjects. In addition, a case-control study was carried out in order to demonstrate the association of diabetic retinopathy with a number of variables. RE…

AdultMalemedicine.medical_specialtyPopulationFundus (eye)OphthalmoscopyCellular and Molecular NeuroscienceAge DistributionRisk FactorsInternal medicineDiabetes mellitusPrevalenceHumansMedicineSex DistributionRisk factoreducationSicilyAgededucation.field_of_studyDiabetic Retinopathymedicine.diagnostic_testbusiness.industryDiabetic Retinopathy Fluorescein Angiography Proliferative Diabetic Retinopathy Fundus Photograph Antidiabetic TreatmentCase-control studyDiabetic retinopathyMiddle Agedmedicine.diseaseFluorescein angiographyHealth SurveysSensory SystemsSurgeryOphthalmologyCase-Control StudiesFemalebusiness
researchProduct

Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a s…

2020

Purpose: to conduct a systematic review with network meta‐analysis (NMA) of randomized clinical trials (RCTs) comparing panretinal photocoagulation (PRP) versus anti‐vascular endothelial growth factor (VEGF) treatment alone or in combination with PRP, for proliferative diabetic retinopathy (PDR).Methods: PubMed, Medline and Embase databases were searched for RCTs comparing PRP versus intravitreal anti‐VEGF therapy and/or combined PRP and intravitreal anti‐VEGF for PDR. The primary outcome measures were the mean best corrected visual acuity (BCVA) change and the regression of neovascularization. Mean change of central macular thickness (CMT), the subgroup analyses of patients without diabeti…

medicine.medical_specialtyBevacizumabgenetic structurespegaptanibmedicine.medical_treatmentPegaptanibNetwork Meta-AnalysisVisual AcuityVitrectomyAngiogenesis Inhibitorsbevacizumablaw.inventionNeovascularization03 medical and health sciences0302 clinical medicineRandomized controlled trialaflibercept; bevacizumab; intravitreal anti-VEGF; panretinal photocoagulation; pegaptanib; proliferative diabetic retinopathy; ranibizumabintravitreal anti-VEGFlawOphthalmologyVitrectomymedicineHumansranibizumabAfliberceptDiabetic RetinopathyLaser Coagulationbusiness.industryafliberceptGeneral MedicineDiabetic retinopathymedicine.diseasepanretinal photocoagulationeye diseasesOphthalmologyIntravitreal Injections030221 ophthalmology & optometrysense organsRanibizumabmedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugproliferative diabetic retinopathy
researchProduct

Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for C…

2019

The study&rsquo

medicine.medical_specialtyYounger agegenetic structuresmedicine.medical_treatmentvitrectomyVitrectomytractional macular detachmentArticle03 medical and health sciences0302 clinical medicineOphthalmologymedicine030212 general & internal medicineanti-VEGF; proliferative diabetic retinopathy; tractional macular detachment; vitrectomyAnti vegfbusiness.industryPrimary vitrectomyIncidence (epidemiology)General MedicineDiabetic retinopathymedicine.diseaseeye diseasesMacular detachmentanti-VEGFVitreous hemorrhage030221 ophthalmology & optometrysense organsbusinessproliferative diabetic retinopathyJournal of Clinical Medicine
researchProduct